Effect of BG-12 (dimethyl fumarate) in newly diagnosed patients with relapsing-remitting multiple sclerosis from the DEFINE and CONFIRM studies

被引：0
|
作者：
Gold, R.
Giovannoni, G.
Phillips, J. T.
Fox, R. J.
Zhang, A.
Meltzer, L.
Kurukulasuriya, N. C.
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[5] Biogen Idec Inc, Weston, MA USA
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O327
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [41] Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
    Lilyana Amezcua
    Yang Mao-Draayer
    Wendy S. Vargas
    Rebecca Farber
    Sara Schaefer
    Filipe Branco
    Sarah M. England
    Nicholas Belviso
    James B. Lewin
    Jason P. Mendoza
    Sai L. Shankar
    Neurology and Therapy, 2023, 12 : 883 - 897
  • [42] Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies
    Amezcua, Lilyana
    Mao-Draayer, Yang S.
    Vargas, Wendy
    Farber, Rebecca
    Schaefer, Sara
    Branco, Filipe M.
    England, Sarah
    Belviso, Nicholas B.
    Lewin, James P.
    Mendoza, Jason L.
    Shankar, Sai
    ENDORSE Study Investigators
    NEUROLOGY AND THERAPY, 2023, 12 (03) : 883 - 897
  • [43] Flushing and gastrointestinal tolerability events in relapsing remitting multiple sclerosis (RRMS) patients treated with oral BG-12 dimethyl fumarate) in the phase 3 DEFINE and CONFIRM trials
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Giovannoni, G.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Viglietta, V.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 221 - 221
  • [44] Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study
    Miller, D. H.
    Hutchinson, M.
    Fox, R. J.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    O'Gorman, J.
    Yang, M.
    Viglietta, V.
    Dawson, K. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 189 - 190
  • [45] Effects of BG-12 on magnetic resonance imaging outcomes in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Miller, D. H.
    Gold, R.
    Fox, R. J.
    MacManus, D.
    Yousry, T.
    Bar-Or, A.
    Zhang, R.
    Viglietta, V.
    Stephan, M.
    Dawson, K. T.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 418 - 418
  • [46] Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the DEFINE study
    Bar-Or, A.
    Gold, R.
    Kappos, L.
    Arnold, D. L.
    Giovannoni, G.
    Selmaj, K.
    O'Gorman, J.
    Stephan, M.
    Dawson, K. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 356 - 356
  • [47] An integrated analysis of safety and tolerability of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from phase 2 and 3 placebo-controlled studies
    Phillips, J. T.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Raghupathi, K.
    Yuan, H.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    Novas, M.
    Sweetser, M. T.
    Selmaj, K.
    JOURNAL OF NEUROLOGY, 2013, 260 : S75 - S75
  • [48] Clinical Efficacy of BG-12 in Relapsing-Remitting Multiple Sclerosis (RRMS): Data from the Phase 3 CONFIRM Study
    Fox, Robert
    Miller, David
    Phillips, J. Theodore
    Kita, Mariko
    Hutchinson, Michael
    Havrdova, Eva
    Yang, Minhua
    Zhang, Ray
    Viglietta, Vissia
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [49] EFFECTS OF BG-12 ON QUALITY OF LIFE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: FINDINGS FROM THE PHASE 3 CONFIRM STUDY
    Kita, M.
    Fox, R. J.
    Phillips, J. T.
    Hutchinson, M.
    Havrdova, E.
    Sarda, S. P.
    Kong, J.
    Viglietta, V.
    Sheikh, S., I
    Dawson, K. T.
    VALUE IN HEALTH, 2012, 15 (07) : A556 - A556
  • [50] Safety and Tolerability of BG-12 (Dimethyl Fumarate) in Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of Phase 2 and 3 Placebo-Controlled Studies
    Phillips, J. Theodore
    Fox, Robert
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Raghupathi, Kartik
    Yuan, Huixing
    Viglietta, Vissia
    Sheikh, Sarah
    Dawson, Katherine
    Novas, Mark
    Sweetser, Marianne
    Selmaj, Krzysztof
    NEUROLOGY, 2013, 80
12345